EAS Newsletter January 14, 2025
Society:
Nominate yourself or someone who truly deserves this recognition for outstanding publications in 2024!
With these annual Young Investigator Awards for outstanding publications, EAS recognizes excellence that contributes to advancing knowledge in the field of atherosclerosis and related metabolic disturbances.
The call for nominations runs until January 31, 2025. Results will be announced in March 2025.
Two recipients (one in basic science and one in clinical research) will each receive a prize of €2000. The award ceremony will take place during the Opening Ceremony of the EAS Congress.
Nominate yourself or someone who truly deserves this recognition! Whether it’s groundbreaking research or impactful clinical insights, this is your chance to spotlight excellence in the field. Submit your nomination and celebrate the future leaders in atherosclerosis research.
To the nomination formCollaborations:
Obesity in patients with familial hypercholesterolaemia globally
The EAS FHSC Investigators at the FHSC Coordinating Centre at Imperial College London present their article titled: Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry that was published today in the European Heart Journal.
This study asks: how frequent is obesity in patients with FH globally, and does it affect their risk of cardiovascular disease?
This study from 6275 children and 29 265 adults provides evidence that obesity is common in those with HeFH globally and is associated with a more severe hyperlipidaemia phenotype and greater likelihood of CVD from childhood.
Given their already augmented risk of ASCVD, patients with FH require intensive lifestyle management aimed at maintaining a healthy weight, in addition to managing lipids with medication, to reduce their lifetime risk of CVD events. Furthermore, these findings reinforce the need for early diagnosis in HeFH including childhood screening to not only manage lipids with pharmacological approaches but to adopt lifestyles that reduce the risk of developing additional cardiovascular risk factors.
A holistic approach, integrating body weight management with LDL-C-lowering treatments, should be used to improve cardiovascular outcomes in people with FH.
Read the articleEducation:
From Greece to Czech Republic: highlights of the 2024 EAS Rare Lipid Disorder Courses
The EAS Rare Lipid Disorder Courses continue to shine as a remarkable success, offering a unique platform to delve into the practical aspects of evaluating and managing rare lipid disorders. These courses, featuring real clinical cases, are expertly organized in collaboration with national societies and delivered as dynamic, one-day stand-alone events. Each program explores rare genetic disorders of lipid metabolism, including ß-sitosterolemia, cerebrotendinous xanthomatosis, lysosomal acid lipase deficiency, high-density lipoprotein disorders, and familial hypocholesterolemias.
We are thrilled to announce that recordings of insightful talks from Greece and the Czech Republic are now available for our members. Please note that some lectures are presented in the local language, adding an authentic touch to these valuable resources.
To the course in Czech RepublicTo the course in GreeceCollaborations:
Discover the latest on diet and lifestyle in CVD prevention
Cardiovascular disease (CVD) remains a leading global health challenge, but there’s good news: adopting the right dietary and lifestyle habits can significantly reduce your risk. To explore this critical topic, we’re excited to share the latest joint partner articles in the Diet at the Heart series, which emphasize the vital role of nutrition in CVD prevention.
These articles are part of an engaging online learning tutorial that dives into how diet and lifestyle choices can help manage dyslipidaemias – a major risk factor for CVD. Whether you’re a healthcare professional or simply eager to improve your heart health, these resources offer invaluable insights.
5. ‘Hot’ topics in dietary management for CVD prevention: Ultra-processed foods and the risk of CVD – Are all ultra-processed foods bad?6. Practical advice for a healthy diet and lifestyle – How to overcome barriers?7. The role of specific dietary factors on cardiovascular disease riskSociety:
Share your experience in 2024 by completing our member satisfaction survey
As we continue to improve our services and programs, we’d love to hear about your experience with us in 2024. Your feedback is invaluable in helping us understand what’s working well and where we can enhance our offerings.
Take a few minutes to complete our member satisfaction survey and share your thoughts.
We will use the results to inform the planning of future activities for our members. For each response we receive, EAS will donate 1 EUR to Médecins Sans Frontières.
Thank you in advance for your support – we look forward to hearing your views!
Take the surveySociety:
EAS Calendar – January-March 2025
From insightful webinars to groundbreaking announcements, this section is your gateway to staying connected and up-to-date with the latest developments within the EAS Society.
December 16 – January 31, Call for nominations: EAS Young Investigator Awards 2025
February 18 – March 11, Late breaking abstract submission: EAS Congress 2025
March 19-21, 2nd Postgraduate Course in Cardiometabolic Medicine
March 21, Joint session at Colombian Congress of Cardiology & Cardiovascular Surgery